These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28904164)

  • 1. Diagnostic Challenges of Postsurgical Breast Cancer Recurrence.
    Castro GJ
    Radiol Technol; 2017 Sep; 89(1):92-94. PubMed ID: 28904164
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracapsular breast implant rupture mimicking local cancer recurrence on
    Domínguez ML; Salvat C; F-Llana B; Vigil C; Suárez JP; González FM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):392-394. PubMed ID: 30031678
    [No Abstract]   [Full Text] [Related]  

  • 3. Imaging surveillance of patients with breast cancer after primary treatment: current recommendations.
    Yoon JH; Kim MJ; Kim EK; Moon HJ
    Korean J Radiol; 2015; 16(2):219-28. PubMed ID: 25741186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET and beyond: molecular breast cancer imaging.
    Quon A; Gambhir SS
    J Clin Oncol; 2005 Mar; 23(8):1664-73. PubMed ID: 15755974
    [No Abstract]   [Full Text] [Related]  

  • 5. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costosternal chondrodynia simulating recurrent breast cancer unveiled by FDG PET.
    Mathew AS; El-Haddad G; Lilien DL; Takalkar AM
    Clin Nucl Med; 2008 May; 33(5):330-2. PubMed ID: 18431146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET/CT in the diagnosis of recurrent breast cancer.
    Murakami R; Kumita S; Yoshida T; Ishihara K; Kiriyama T; Hakozaki K; Yanagihara K; Iida S; Tsuchiya S
    Acta Radiol; 2012 Feb; 53(1):12-6. PubMed ID: 22067206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
    Eubank WB
    Radiol Clin North Am; 2007 Jul; 45(4):659-67, vi. PubMed ID: 17706530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of breast and gynecologic cancers by positron emission tomography.
    Dehdashti F; Siegel BA
    Semin Roentgenol; 2002 Apr; 37(2):151-68. PubMed ID: 12134368
    [No Abstract]   [Full Text] [Related]  

  • 10. False-positive positron emission tomographic scan for recurrent breast cancer resulting from a bee sting.
    Johnson DS; Wong JT; Coel MN
    Clin Nucl Med; 1999 Sep; 24(9):702-3. PubMed ID: 10478754
    [No Abstract]   [Full Text] [Related]  

  • 11. F-18 FDG positron emission tomographic imaging in a case of ruptured breast implant: inflammation or recurrent tumor?
    Hurwitz R
    Clin Nucl Med; 2003 Sep; 28(9):755-6. PubMed ID: 12972998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET scan detects recurrent breast cancer.
    Health News; 2002 May; 8(5):9. PubMed ID: 12132415
    [No Abstract]   [Full Text] [Related]  

  • 13. Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.
    Bénard F; Turcotte E
    Breast Cancer Res; 2005; 7(4):153-62. PubMed ID: 15987467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume-based parameters of 18F-fluorodeoxyglucose positron emission tomography/computed tomography improve disease recurrence prediction in postmastectomy breast cancer patients with 1 to 3 positive axillary lymph nodes.
    Nakajima N; Kataoka M; Sugawara Y; Ochi T; Kiyoto S; Ohsumi S; Mochizuki T
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):738-46. PubMed ID: 24064322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography.
    Kubota K; Matsuzawa T; Amemiya A; Kondo M; Fujiwara T; Watanuki S; Ito M; Ido T
    J Comput Assist Tomogr; 1989; 13(6):1097-8. PubMed ID: 2584499
    [No Abstract]   [Full Text] [Related]  

  • 16. Current and future use of positron emission tomography (PET) in breast cancer.
    Mankoff DA; Eubank WB
    J Mammary Gland Biol Neoplasia; 2006 Apr; 11(2):125-36. PubMed ID: 17075687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of 18F-FDG-PET in breast cancer imaging].
    Tayama K; Toh U; Fujii T; Shirouzu K; Kaida Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():373-8. PubMed ID: 17679209
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
    Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer.
    Kamel EM; Wyss MT; Fehr MK; von Schulthess GK; Goerres GW
    J Cancer Res Clin Oncol; 2003 Mar; 129(3):147-53. PubMed ID: 12712329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
    Landheer ML; Steffens MG; Klinkenbijl JH; Westenberg AH; Oyen WJ
    Br J Surg; 2005 Nov; 92(11):1363-7. PubMed ID: 16187254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.